Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT

BMC Cell Biology

Volumn 7, Issue , 2006, Pages

  Machuca, Catalina ^a,b   Mendoza Milla, Criselda ^b   Córdova, Emilio ^b,c   Mejía, Salvador ^b   Covarrubias, Luis ^d   Ventura, José ^c   Zentella, Alejandro ^b,c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^d INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STEROID RECEPTOR; CELL CYCLE PROTEIN; DUSP1 PROTEIN, HUMAN; GLUCOCORTICOID RECEPTOR; IMMEDIATE EARLY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; ONCOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE; SERUM GLUCOCORTICOID REGULATED KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE; TUMOR NECROSIS FACTOR ALPHA; X LINKED INHIBITOR OF APOPTOSIS; XIAP PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER RESISTANCE; CELL DEATH; CELL PROTECTION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; CYTOTOXICITY; GENE OVEREXPRESSION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR CLONING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; APOPTOSIS; BREAST TUMOR; CELL SURVIVAL; DRUG EFFECT; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

INTRACISTERNAL A-PARTICLES; MINK CELL FOCUS-FORMING VIRUS;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DEXAMETHASONE; DUAL SPECIFICITY PHOSPHATASE 1; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMEDIATE-EARLY PROTEINS; INHIBITOR OF APOPTOSIS PROTEINS; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN PHOSPHATASE 1; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GLUCOCORTICOID; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 33644803764     PISSN: 14712121     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-7-9     Document Type: Article

References (43)

1. Muti P: The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence. Recent Results Cancer Res 2005, 166:245-256.
2. Balkwill F: Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 2002, 13:135-141.
3. Lejeune FJ, Ruegg C, Lienard D: Clinical applications of TNF-alpha in cancer. Curr Opin Immunol 1998, 10:573-580.
4. Donato NJ, Klostergaard J: Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells. Exp Cell Res 2004, 294:523-533.
5. Liu ZG: Molecular mechanism of TNF signaling and beyond. Cell Res 2005, 15:24-27.
6. Dempsey PW, Doyle SE, He JQ, Cheng G: The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003, 14:193-209.
7. Gupta S: A decision between life and death during TNF-alpha-induced signaling. J Clin Immunol 2002, 22:185-194.
8. Greenstein S, Ghias K, Krett NL, Rosen ST: Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 2002, 8:1681-1694.
9. Lipworth BJ: Therapeutic implications of non-genomic glucocorticoid activity. Lancet 2000, 356:87-89.
10. Distelhorst CW: Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002, 9:6-19.
11. Bailly-Maitre B, de Sousa G, Zucchini N, Gugenheim J, Boulukos KE, Rahmani R: Spontaneous apoptosis in primary cultures of human and rat hepatocytes: molecular mechanisms and regulation by dexamethasone. Cell Death Differ 2002, 9:945-955.
12. Newton CJ, Xie YX, Burgoyne CH, Adams I, Atkin SL, Abidia A, McCollum PT: Fluvastatin induces apoptosis of vascular endothelial cells: blockade by glucocorticoids. Cardiovasc Surg 2003, 11:52-60.
13. Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL, Parfitt AM, Manolagas SC: Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 2002, 109:1041-1048.
14. Moran TJ, Gray S, Mikosz CA, Conzen SD: The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res 2000, 60:867-872.
15. Pagliacci MC, Fumi G, Migliorati G, Grignani F, Riccardi C, Nicoletti I: Cytostatic and cytotoxic effects of tumor necrosis factor alpha on MCF-7 human breast tumor cells are differently inhibited by glucocorticoid hormones. Lymphokine Cytokine Res 1993, 12:439-447.
16. Messmer UK, Pereda-Fernandez C, Manderscheid M, Pfeilschifter J: Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells. Br J Pharmacol 2001, 133:467-476.
17. Beg AA, Baltimore D: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996, 274:782-784.
18. Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000, 18:621-663.
19. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr: NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281:1680-1683.
20. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274:787-789.
21. Downward J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 1998, 10:262-267.
22. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC: Regulation of cell death protease caspase-9 by phosphorylation. Science 1998, 282:1318-1321.
23. Burow ME, Weldon CB, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Beckman BS: Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J Biol Chem 2000, 275:9628-9635.
24. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB: NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401:82-85.
25. Burow ME, Weldon CB, Melnik LI, Duong BN, Collins-Burow BM, Beckman BS, McLachlan JA: PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem Biophys Res Commun 2000, 271:342-345.
26. Sandra F, Matsuki NA, Takeuchi H, Ikebe T, Kanematsu T, Ohishi M, Hirata M: TNF inhibited the apoptosis by activation of Akt serine/threonine kinase in the human head and neck squamous cell carcinoma. Cell Signal 2002, 14:771-778.
27. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB: Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 2004, 279:1615-1620.
28. Lacroix M, Leclercq G: Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004, 83:249-289.
29. Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, Beckman BS: Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res 1998, 58:4940-4946.
30. Pastorino JG, Tafani M, Farber JL: Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway. J Biol Chem 1999, 274:19411-19416.
31. Madge LA, Pober JS: A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J Biol Chem 2000, 275:15458-15465.
32. Reddy SA, Huang JH, Liao WS: Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. J Immunol 2000, 164:1355-1363.
33. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
34. Zou T, Rao JN, Guo X, Liu L, Zhang HM, Strauch ED, Bass BL, Wang JY: NF-kappaB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion. Am J Physiol Cell Physiol 2004, 286:C1009-1018.
35. Chen X, Kandasamy K, Srivastava RK: Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res 2003, 63:1059-1066.
36. Sur P, Sribnick EA, Patel SJ, Ray SK, Banik NL: Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. Glia 2005, 50:160-167.
37. Hundertmark S, Buhler H, Rudolf M, Weitzel HK, Ragosch V: Inhibition of 11 beta-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells. J Endocrinol 1997, 155:171-180.
38. Webster MK, Guthrie J, Firestone GL: Suppression of rat mammary tumor cell growth in vitro by glucocorticoids requires serum proteins. Characterization of wild type and glucocorticoid-resistant epithelial tumor cells. J Biol Chem 1990, 265:4831-4838.
39. Scott FL, Denault JB, Riedl SJ, Shin H, Renatus M, Salvesen GS: XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J 2005, 24:645-655.
40. Yoshida NL, Miyashita T, U M, Yamada M, Reed JC, Sugita Y, Oshida T: Analysis of gene expression patterns during glucocorticoid-induced apoptosis using oligonucleotide arrays. Biochem Biophys Res Commun 2002, 293:1254-1261.
41. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD: Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 2004, 64:1757-1764.
42. Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, Kitamura T, Kitamura Y, Ueda H, Stephens L, Jackson TR, Hawkins PT, Dhand R, Clark AE, Holman GD, Waterfield MD, Kasuga M: 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci USA 1994, 91:7415-7419.
43. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW: Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol 1995, 15:2809-2818.